Development of a "new generation" monitoring system of passive smoking based on antibody engineering approach
| Project/Area Number |
23790632
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | Kobe Pharmaceutical University |
|---|
Principal Investigator |
MORITA Izumi 神戸薬科大学, 薬学部, 助手 (20299085)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 抗体工学 / 受動喫煙 / バイオテクノロジー / 分析科学 / 社会医学 |
|---|
| Research Abstract |
We previously established a hybridoma clone which produces an anti-cotinine antibody and "wild type" scFv is prepared by combining the V_H and V_L domains of theantibody. Using this scFv gene as a template, a variety of scFv gene library is produced, from which ascFv clones with a higher affinity were obtained. The conditions of competitive ELISA using thesescFvs are optimized, and consequently, the assay sensitivity was largely improved compared with theconventional ELISA using a mouse antibody. This assay system was applicable to the determination ofhuman urinary cotinine levels, and is expected to be useful for monitoring of passive smoking.
|
Report
(3 results)
Research Products
(9 results)
